Log in

OTCMKTS:FPMI - Fluoropharma Medical Stock Price, Forecast & News

0.00 (0.00 %)
(As of 02/23/2020 03:32 AM ET)
Today's Range
Now: $0.00
50-Day Range N/A
52-Week Range
Now: $0.00
Volume7,000 shs
Average Volume20,751 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.

Industry, Sector and Symbol

Industry Diagnostic substances
Current SymbolOTCMKTS:FPMI



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive FPMI News and Ratings via Email

Sign-up to receive the latest news and ratings for FPMI and its competitors with MarketBeat's FREE daily newsletter.

Fluoropharma Medical (OTCMKTS:FPMI) Frequently Asked Questions

What is Fluoropharma Medical's stock symbol?

Fluoropharma Medical trades on the OTCMKTS under the ticker symbol "FPMI."

How were Fluoropharma Medical's earnings last quarter?

Fluoropharma Medical Inc (OTCMKTS:FPMI) issued its earnings results on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.06) by $0.01. View Fluoropharma Medical's Earnings History.

Has Fluoropharma Medical been receiving favorable news coverage?

News coverage about FPMI stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Fluoropharma Medical earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned news headlines about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Fluoropharma Medical.

Who are some of Fluoropharma Medical's key competitors?

What other stocks do shareholders of Fluoropharma Medical own?

Who are Fluoropharma Medical's key executives?

Fluoropharma Medical's management team includes the folowing people:
  • Dr. Thomas H. Tulip, CEO, Pres & Director (Age 66)
  • Ms. Tamara Rhein, Chief Financial Officer (Age 47)
  • Mr. Edward L. Lyons Jr., VP of Devel.

How do I buy shares of Fluoropharma Medical?

Shares of FPMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Fluoropharma Medical's stock price today?

One share of FPMI stock can currently be purchased for approximately $0.00.

What is Fluoropharma Medical's official website?

The official website for Fluoropharma Medical is http://www.fluoropharma.com/.

How can I contact Fluoropharma Medical?

Fluoropharma Medical's mailing address is 8 Hillside Avenue Suite 108, Montclair NJ, 07042. The biopharmaceutical company can be reached via phone at 973-744-1565 or via email at [email protected]

MarketBeat Community Rating for Fluoropharma Medical (OTCMKTS FPMI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about Fluoropharma Medical and other stocks. Vote "Outperform" if you believe FPMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FPMI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel